We are live on ! Find out more
SAM

Shell Asset Management Portfolio holdings

AUM $996M
1-Year Est. Return 26.19%
This Fund
S&P 500
This Quarter Est. Return
-11.31%
1 Year Est. Return
+26.19%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$4.01B
AUM Growth
-$1.05B
Cap. Flow
-$417M
Cap. Flow %
-10.41%
Top 10 Hldgs %
14.78%
Holding
1,171
New
12
Increased
136
Reduced
895
Closed
33

Sector Composition

Rank Sector Weight
1 Technology 16.68%
2 Financials 15.8%
3 Healthcare 11.89%
4 Consumer Discretionary 10.77%
5 Communication Services 8.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SIR
1001
DELISTED
SELECT INCOME REIT
SIR
$267K 0.01%
36,235
-53,252
-60% -$447K
CC icon
1002
Chemours
CC
$2.48B
$266K 0.01%
9,423
-2,676
-22% -$84.6K
VC icon
1003
Visteon
VC
$2.85B
$266K 0.01%
4,417
-400
-8% -$30.2K
OII icon
1004
Oceaneering
OII
$4.64B
$263K 0.01%
21,717
-1,800
-8% -$33.9K
PTEN icon
1005
Patterson-UTI
PTEN
$3.54B
$262K 0.01%
25,347
-2,100
-8% -$30.9K
AAWW
1006
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
$262K 0.01%
6,210
-500
-7% -$25.6K
ACB
1007
Aurora Cannabis
ACB
$169M
$258K 0.01%
+433
New +$319K
VET icon
1008
Vermilion Energy
VET
$1.66B
$256K 0.01%
12,142
-1,800
-13% -$46.7K
SABR icon
1009
Sabre
SABR
$716M
$255K 0.01%
11,771
-5,862
-33% -$142K
FBNC icon
1010
First Bancorp
FBNC
$2.61B
$253K 0.01%
7,745
-600
-7% -$22.4K
R icon
1011
Ryder
R
$9.9B
$242K 0.01%
5,018
-400
-7% -$22.9K
HRTX icon
1012
Heron Therapeutics
HRTX
$93.4M
$240K 0.01%
9,271
-800
-8% -$22K
NOAH
1013
Noah Holdings
NOAH
$590M
$240K 0.01%
5,551
+951
+21% +$39.5K
QNST icon
1014
QuinStreet
QNST
$927M
$239K 0.01%
14,751
-1,200
-8% -$18K
FBIN icon
1015
Fortune Brands Innovations
FBIN
$5.86B
$238K 0.01%
7,337
-3,357
-31% -$127K
S
1016
DELISTED
Sprint Corporation
S
$238K 0.01%
40,864
NEWR
1017
DELISTED
New Relic, Inc.
NEWR
$237K 0.01%
2,923
-300
-9% -$25.3K
PBCT
1018
DELISTED
People's United Financial Inc
PBCT
$237K 0.01%
16,406
-12,775
-44% -$202K
BPMC
1019
DELISTED
Blueprint Medicines
BPMC
$235K 0.01%
4,366
-400
-8% -$24.3K
SAGE
1020
DELISTED
Sage Therapeutics
SAGE
$232K 0.01%
2,420
-200
-8% -$22.9K
ACAD icon
1021
Acadia Pharmaceuticals
ACAD
$4.51B
$231K 0.01%
14,259
-1,200
-8% -$23.3K
RARE icon
1022
Ultragenyx Pharmaceutical
RARE
$2.46B
$230K 0.01%
5,301
-400
-7% -$21.9K
TSG
1023
DELISTED
The Stars Group Inc.
TSG
$230K 0.01%
13,951
+588
+4% +$11.5K
FTDR icon
1024
Frontdoor
FTDR
$5.27B
$229K 0.01%
+8,618
New +$255K
EGRX
1025
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$228K 0.01%
5,667
-500
-8% -$25.8K

Similar funds

Shell Asset Management's Q4 2018 Portfolio in Review

As of Q4 2018, Shell Asset Management held 1,171 positions worth $4.01B, down 21% from $5.07B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Shell Asset Management withdrew a net $417M in Q4 2018, closing 33 positions and reducing 895 holdings. Its most notable exit was Aetna Inc, an estimated $12.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 19% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Shell Asset Management opened a new position in HUTCHMED worth $1.05M.

  • Shell Asset Management's largest Q4 2018 buy was HUTCHMED: 45,448 shares worth $1.05M.
  • Shell Asset Management added most to Barrick Mining in Q4 2018, an estimated $13.1M increase.
  • Shell Asset Management's biggest Q4 2018 reduction was Apple, cutting an estimated $16.5M.
  • Shell Asset Management fully exited Aetna Inc in Q4 2018, selling an estimated $12.4M.
  • Shell Asset Management's ten largest holdings make up 15% of its $4.01B portfolio in Q4 2018.
  • Shell Asset Management opened 12 new positions and closed 33 in Q4 2018.
  • Shell Asset Management's portfolio value fell 21% quarter-over-quarter to $4.01B.

Based on Shell Asset Management's 13F filing for Q4 2018, filed 13 Feb 2019.